From: A novel method for predicting hepatocellular carcinoma response to chemoembolization using an intraprocedural CT hepatic arteriography-based enhancement mapping: a proof-of-concept analysis
First follow-up imaging, mRECIST
Non-complete response, i.e., partial response or stable disease (n = 19)
Complete response (n = 27)
CTHA-EM
Residual tumor
(n = 18)
18
0
Non-residual tumor
(n = 28)
1
27